NCT05461183

Brief Summary

For every case of maternal death, many more women experience life-threatening complications during pregnancy and childbirth. Yet, severe maternal morbidity (SMM) cases are often overlooked post-delivery. Women have reported that roughly 15% of SMM cases first occurred in the six weeks following delivery. The underlying factors associated with these morbidities are likely different than those occurring antenatally and at the time of delivery. Further research is required to elucidate the exact burden of SMM in the postpartum period in British Columbia (BC).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2008

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
13 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

July 18, 2022

Status Verified

July 1, 2022

Enrollment Period

13 years

First QC Date

July 13, 2022

Last Update Submit

July 13, 2022

Conditions

Keywords

severe maternal morbiditypostpartum periodhospital readmission

Outcome Measures

Primary Outcomes (2)

  • Maternal hospital readmission

    Cumulative incidence of women who get readmitted into the hospital after being discharged post-delivery

    Up to six weeks post-delivery discharge

  • Severe maternal morbidity (SMM) event

    Cumulative incidence of women who experience least one SMM event, defined as: severe pre-eclampsia, HELLP, eclampsia; severe haemorrhage; maternal ICU admission; surgical complications; hysterectomy; sepsis; embolism, shock, DIC; assisted ventilation; cardiac conditions; acute renal failure; several uterine rupture; cerebrovascular accidents; and other types of maternal morbidity.

    Up to six weeks post-delivery discharge

Secondary Outcomes (4)

  • SMM type

    Up to six weeks postpartum

  • Rate of hospital readmission and SMM events

    Up to six weeks postpartum

  • Timing of hospital readmission and SMM events

    Up to six weeks postpartum

  • Maternal characteristics

    Up to six weeks postpartum

Study Arms (3)

Readmission/ SMM post-delivery discharge

All women aged 15-49 who were readmitted up to six weeks post-delivery discharge and/or experienced at least one SMM event up to six weeks post-delivery

Other: Retrospective database analysis

De novo readmission/ SMM post-delivery discharge

All women aged 15-49 who were readmitted up to six weeks post-delivery discharge and/or experienced at least one SMM event post-delivery, excluding those who experienced a SMM in the two months before delivery or during delivery hospitalization

Other: Retrospective database analysis

No post-delivery discharge readmission/ SMM at any time (CONTROL)

All women aged 15-49 who did not experience post-delivery discharge readmission and/or SMM at any time

Other: Retrospective database analysis

Interventions

This study will review data provided by the BCPDR from April 1, 2008 to March 31, 2021.

De novo readmission/ SMM post-delivery dischargeNo post-delivery discharge readmission/ SMM at any time (CONTROL)Readmission/ SMM post-delivery discharge

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Those who delivered between April 1, 2008 to March 31, 2021 using data from the BC Perinatal Data Registry (BCPDR).

You may qualify if:

  • Delivered in BC from April 1, 2008 to March 31, 2021
  • Consented to data collected by the BCPDR

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Geller SE, Koch AR, Garland CE, MacDonald EJ, Storey F, Lawton B. A global view of severe maternal morbidity: moving beyond maternal mortality. Reprod Health. 2018 Jun 22;15(Suppl 1):98. doi: 10.1186/s12978-018-0527-2.

    PMID: 29945657BACKGROUND
  • Dzakpasu S, Deb-Rinker P, Arbour L, Darling EK, Kramer MS, Liu S, Luo W, Murphy PA, Nelson C, Ray JG, Scott H, VandenHof M, Joseph KS. Severe maternal morbidity surveillance: Monitoring pregnant women at high risk for prolonged hospitalisation and death. Paediatr Perinat Epidemiol. 2020 Jul;34(4):427-439. doi: 10.1111/ppe.12574. Epub 2019 Aug 12.

    PMID: 31407359BACKGROUND

MeSH Terms

Conditions

Pregnancy Complications

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 13, 2022

First Posted

July 18, 2022

Study Start

April 1, 2008

Primary Completion

March 31, 2021

Study Completion

January 1, 2023

Last Updated

July 18, 2022

Record last verified: 2022-07